Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalom Chinedu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|March 16, 2026
Heme oxygenase-1 and malaria pathogenesisTheophilus Wakai, Shalom Chinedu, Israel Afolabi
Frontiers in Immunology|June 1, 2026
Plasma haem oxygenase-1 and interleukin-6 as adjunct host biomarkers associated with malariaTheophilus Wakai, Irrinus Kintung, Temitayo Ogundimu, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 30, 2021
Computational identification of Plasmodium falciparum RNA pseudouridylate synthase as a viable drug target, its physicochemical properties, 3D structure prediction and prediction of potential inhibitorsRufus Afolabi, Shalom Chinedu, Yvonne Ajamma, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|March 16, 2026
Heme oxygenase-1 and malaria pathogenesisTheophilus Wakai, Shalom Chinedu, Israel Afolabi
Frontiers in Immunology|June 1, 2026
Plasma haem oxygenase-1 and interleukin-6 as adjunct host biomarkers associated with malariaTheophilus Wakai, Irrinus Kintung, Temitayo Ogundimu, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 30, 2021
Computational identification of Plasmodium falciparum RNA pseudouridylate synthase as a viable drug target, its physicochemical properties, 3D structure prediction and prediction of potential inhibitorsRufus Afolabi, Shalom Chinedu, Yvonne Ajamma, et al.
Pageof 1